Announced Tue, 23 Jun · 12:09 IST
Trading Window Closed from July 1 for Q1 FY27 Results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹29.79
prior close
₹29.59
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.2+0.2-0.3-1.4-0.6-3.8-3.0-3.3+8.7+16.4+8.7——
Up moveDown movePending
AI summary
Shukra Pharmaceuticals is closing its trading window from July 1, 2026 until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. Promoters, directors, KMPs, designated persons, connected persons and their immediate relatives cannot trade in the company securities during this period. The board meeting date to approve results will be announced separately. This is a routine compliance measure under SEBI insider trading regulations.
Likely market impact
Routine insider trading compliance; no direct impact on shareholders. Signals upcoming Q1 FY27 results announcement soon.